| Literature DB >> 29625067 |
Xiuxing Wang1, Briana C Prager2, Qiulian Wu1, Leo J Y Kim3, Ryan C Gimple3, Yu Shi4, Kailin Yang5, Andrew R Morton6, Wenchao Zhou7, Zhe Zhu1, Elisabeth Anne Adanma Obara8, Tyler E Miller9, Anne Song5, Sisi Lai7, Christopher G Hubert7, Xun Jin7, Zhi Huang7, Xiaoguang Fang7, Deobrat Dixit1, Weiwei Tao7, Kui Zhai7, Cong Chen7, Zhen Dong1, Guoxin Zhang1, Stephen M Dombrowski5, Petra Hamerlik8, Stephen C Mack10, Shideng Bao7, Jeremy N Rich11.
Abstract
Glioblastoma is the most lethal primary brain tumor; however, the crosstalk between glioblastoma stem cells (GSCs) and their supportive niche is not well understood. Here, we interrogated reciprocal signaling between GSCs and their differentiated glioblastoma cell (DGC) progeny. We found that DGCs accelerated GSC tumor growth. DGCs preferentially expressed brain-derived neurotrophic factor (BDNF), whereas GSCs expressed the BDNF receptor NTRK2. Forced BDNF expression in DGCs augmented GSC tumor growth. To determine molecular mediators of BDNF-NTRK2 paracrine signaling, we leveraged transcriptional and epigenetic profiles of matched GSCs and DGCs, revealing preferential VGF expression by GSCs, which patient-derived tumor models confirmed. VGF serves a dual role in the glioblastoma hierarchy by promoting GSC survival and stemness in vitro and in vivo while also supporting DGC survival and inducing DGC secretion of BDNF. Collectively, these data demonstrate that differentiated glioblastoma cells cooperate with stem-like tumor cells through BDNF-NTRK2-VGF paracrine signaling to promote tumor growth.Entities:
Keywords: BDNF; NTRK2; VGF; cancer stem cell; differentiated glioma cell; glioblastoma; glioma stem cell; neurotrophin
Mesh:
Year: 2018 PMID: 29625067 PMCID: PMC5947947 DOI: 10.1016/j.stem.2018.03.011
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633